Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sutro Biopharma Inc (STRO)
NASDAQ:STRO
Sutro Biopharma (STRO) Stock Price & Analysis
183 Followers
STRO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.03 - $8.72
Previous Close$3.64
Volume206.60K
Average Volume (3M)386.12K
Market Cap
$220.32M
Enterprise Value-$128.67M
Total Cash (Recent Filing)$391.64M
Total Debt (Recent Filing)$42.66M
Price to Earnings (P/E)-1.5
Beta1.05
Next Earnings
Nov 09, 2023EPS Estimate
-$0.73Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.47
Shares Outstanding60,527,043
10 Day Avg. Volume807,356
30 Day Avg. Volume386,118
Standard Deviation0.16
R-Squared0.10
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)1.54
Price to Sales (P/S)21.16
Price to Cash Flow (P/CF)-1.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-4.06
Enterprise Value/Gross Profit-1.90
Enterprise Value/Ebitda1.04
Forecast
1Y Price Target
$13.50Price Target Upside283.52% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Sutro Biopharma News
Pre-EarningsSutro Biopharma (STRO) Q2 Earnings Cheat Sheet
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
STRO FAQ
What was Sutro Biopharma Inc’s price range in the past 12 months?
Sutro Biopharma Inc lowest stock price was $3.03 and its highest was $8.72 in the past 12 months.
What is Sutro Biopharma Inc’s market cap?
Currently, no data Available
When is Sutro Biopharma Inc’s upcoming earnings report date?
Sutro Biopharma Inc’s upcoming earnings report date is Nov 09, 2023 which is in 21 days.
How were Sutro Biopharma Inc’s earnings last quarter?
Sutro Biopharma Inc released its earnings results on Aug 10, 2023. The company reported -$0.64 earnings per share for the quarter, beating the consensus estimate of -$0.732 by $0.092.
Is Sutro Biopharma Inc overvalued?
According to Wall Street analysts Sutro Biopharma Inc’s price is currently Undervalued.
Does Sutro Biopharma Inc pay dividends?
Sutro Biopharma Inc does not currently pay dividends.
What is Sutro Biopharma Inc’s EPS estimate?
Sutro Biopharma Inc’s EPS estimate is -$0.73.
How many shares outstanding does Sutro Biopharma Inc have?
Sutro Biopharma Inc has 60,527,042 shares outstanding.
What happened to Sutro Biopharma Inc’s price movement after its last earnings report?
Sutro Biopharma Inc reported an EPS of -$0.64 in its last earnings report, beating expectations of -$0.732. Following the earnings report the stock price went down -1.843%.
Which hedge fund is a major shareholder of Sutro Biopharma Inc?
Among the largest hedge funds holding Sutro Biopharma Inc’s share is Fisher Asset Management LLC. It holds Sutro Biopharma Inc’s shares valued at 914K.
---
Sutro Biopharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.50 (283.52% Upside)
$13.50 (283.52% Upside)
Blogger Sentiment
Bullish
STRO Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 188.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $53.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.91%
12-Months-Change
Fundamentals
Return on Equity
-78.43%
Trailing 12-Months
Asset Growth
20.56%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Sutro Biopharma Inc
Sutro Biopharma Inc. engages in the drug discovery, development and manufacturing of pharmaceutical products. Its products technologies include XpressCF, anti-body drug conjugates, bispecifics & engineered antibodies and cGMP facility. The company was founded by James R. Swartz and Sutanto Widjaja in June 2003 and is headquartered in South San Francisco, CA.
---
Top 5 ETFs holding STRO
Vanguard Total Stock Market ETF
$5.93M
iShares Core S&P Total U.S. Stock Market ETF
$401.33K
iShares Russell 3000 ETF
$87.52K
Vanguard Russell 3000 ETF
$14.04K
Dimensional U.S. Equity ETF
$8.28K
Up to five ETFs with an Outperform Smart Score that hold STRO. The ETFs are listed according to market value of STRO within the ETF
Adaptimmune Therapeutics
―
Adaptive Biotechnologies
―
Alpine Immune Sciences
―
Amarin
―
---